Tolerance and Immunity in Mice Infected with Herpes Simplex Virus: Simultaneous Induction of Protective Immunity and Tolerance to Delayed-type Hypersensitivity
Overview
Affiliations
Unresponsiveness to delayed type hypersensitivity was induced in mice following an intravenous injection of herpes simplex virus. The principal tolerogens used were thymidine kinase-deficient virus mutants which grow poorly in vivo; u.v.-inactivated and to a lesser extent formalin-inactivated virus were also tolerogenic. The tolerance induced was specific for the virus type. Despite the tolerance to delayed hypersensitivity, anti-viral immunity is present as determined by the rapid inactivation of infectious virus. The mechanism of tolerance to herpes virus and the importance of these observations for the pathogenesis of viral disease is discussed.
Immunological aspects of acute and recurrent herpes simplex keratitis.
Rolinski J, Hus I J Immunol Res. 2014; 2014:513560.
PMID: 25276842 PMC: 4170747. DOI: 10.1155/2014/513560.
Geiss B, Smith T, Leib D, Morrison L J Virol. 2000; 74(23):11137-44.
PMID: 11070010 PMC: 113198. DOI: 10.1128/jvi.74.23.11137-11144.2000.
Clark C, Dalmasso A Immunology. 1982; 47(1):19-29.
PMID: 7118159 PMC: 1555501.
Role of T-lymphocyte subsets in recovery from herpes simplex virus infection.
Larsen H, Feng M, Horohov D, Moore R, Rouse B J Virol. 1984; 50(1):56-9.
PMID: 6608007 PMC: 255581. DOI: 10.1128/JVI.50.1.56-59.1984.
Rouse B, Wagner H Immunology. 1984; 51(1):57-64.
PMID: 6317545 PMC: 1454414.